- Home
- ELTX vs PLCE Comparison
ELTX vs PLCE Comparison
Compare ELTX & PLCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTX
- PLCE
- Stock Information
- Founded
- ELTX 2011
- PLCE 1969
- Country
- ELTX United States
- PLCE United States
- Employees
- ELTX N/A
- PLCE N/A
- Industry
- ELTX Biotechnology: Pharmaceutical Preparations
- PLCE Clothing/Shoe/Accessory Stores
- Sector
- ELTX Health Care
- PLCE Consumer Discretionary
- Exchange
- ELTX Nasdaq
- PLCE Nasdaq
- Market Cap
- ELTX 158.5M
- PLCE 169.6M
- IPO Year
- ELTX N/A
- PLCE 1997
- Fundamental
- Price
- ELTX $9.13
- PLCE $7.69
- Analyst Decision
- ELTX Strong Buy
- PLCE Hold
- Analyst Count
- ELTX 1
- PLCE 1
- Target Price
- ELTX $13.00
- PLCE $8.00
- AVG Volume (30 Days)
- ELTX 102.3K
- PLCE 614.7K
- Earning Date
- ELTX 11-07-2025
- PLCE 12-02-2025
- Dividend Yield
- ELTX N/A
- PLCE N/A
- EPS Growth
- ELTX N/A
- PLCE N/A
- EPS
- ELTX N/A
- PLCE N/A
- Revenue
- ELTX N/A
- PLCE $1,338,867,000.00
- Revenue This Year
- ELTX N/A
- PLCE N/A
- Revenue Next Year
- ELTX N/A
- PLCE $0.68
- P/E Ratio
- ELTX N/A
- PLCE N/A
- Revenue Growth
- ELTX N/A
- PLCE N/A
- 52 Week Low
- ELTX $4.60
- PLCE $3.66
- 52 Week High
- ELTX $12.62
- PLCE $17.19
- Technical
- Relative Strength Index (RSI)
- ELTX 34.25
- PLCE 53.02
- Support Level
- ELTX $9.03
- PLCE $6.76
- Resistance Level
- ELTX $9.55
- PLCE $8.87
- Average True Range (ATR)
- ELTX 0.46
- PLCE 0.77
- MACD
- ELTX -0.04
- PLCE -0.18
- Stochastic Oscillator
- ELTX 9.65
- PLCE 43.06
About ELTX Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.
About PLCE Children's Place Inc. (The)
Children's Place Inc operate an omni-channel children's specialty portfolio of brands in North America. It designs, contract to manufacture, and sell fashionable, high-quality apparel, accessories and footwear predominantly at value prices under proprietary The Children's Place, Place, Baby Place, Gymboree, Sugar & Jade, and PJ Place brand names. The Company classifies its business into two segments: The Children's Place U.S. and The Children's Place International.